⬆ Pfizer Inc - Pfizer reported robust 4Q25 results, with revenue of US$17.6bn (largely in-line with our estimate of US$18.1bn) and adj. net income of US$3.8bn (outperforming our estimates of US$3.3bn).

Continue reading on Smartkarma:- https://www.smartkarma.com/insights/pfizer-inc-pfe-us-obesity-pipeline-de-risking-drives-re-rating-potential?utm_source=tiger_community

By CMB International, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cmb-international?utm_source=tiger_community

On Pfizer Inc (PFE):- https://www.smartkarma.com/entities/pfizer-inc?utm_source=tiger_community

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.